varenicline has been researched along with Diabetes Mellitus in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brath, H; Fasching, P; Kaser, S; Tatschl, C | 1 |
| Azrin, ST; Baller, J; Daumit, GL; Juliano-Bult, D; McGinty, EE | 1 |
| Abe, TO; Gaya, PV; Pereira, AC; Pinheiro, GG; Santos, PC; Scholz, J; Silva, AP | 1 |
| Achtyes, ED; Cather, C; Evins, AE; Hoeppner, SS; Pachas, GN; Pratt, S; Thorndike, AN | 1 |
2 review(s) available for varenicline and Diabetes Mellitus
| Article | Year |
|---|---|
[Smoking, alcohol and diabetes (Update 2019)].
Topics: Alcohol Drinking; Benzazepines; Bupropion; Diabetes Mellitus; Humans; Nicotine; Practice Guidelines as Topic; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2019 |
Interventions to Address Medical Conditions and Health-Risk Behaviors Among Persons With Serious Mental Illness: A Comprehensive Review.
Topics: Behavior Therapy; Bipolar Disorder; Bupropion; Cardiovascular Diseases; Diabetes Mellitus; Dopamine Uptake Inhibitors; Health Behavior; HIV Infections; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Metformin; Motor Activity; Nicotinic Agonists; Obesity; Overweight; Risk Reduction Behavior; Schizophrenia; Smoking; Smoking Cessation; Varenicline | 2016 |
1 trial(s) available for varenicline and Diabetes Mellitus
| Article | Year |
|---|---|
Weight gain and 10-year cardiovascular risk with sustained tobacco abstinence in smokers with serious mental illness: a subgroup analysis of a randomized trial.
Topics: Cardiovascular Diseases; Diabetes Mellitus; Female; Humans; Hypertension; Male; Mental Disorders; Middle Aged; Obesity; Remission Induction; Smoking Cessation; Varenicline; Weight Gain | 2016 |
1 other study(ies) available for varenicline and Diabetes Mellitus
| Article | Year |
|---|---|
Influence of smoking cessation drugs on blood pressure and heart rate in patients with cardiovascular disease or high risk score: real life setting.
Topics: Adult; Aged; Blood Pressure; Brazil; Bupropion; Cardiovascular Diseases; Comorbidity; Coronary Artery Disease; Diabetes Mellitus; Diastole; Dopamine Uptake Inhibitors; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nicotine; Nicotinic Agonists; Risk Factors; Smoking; Smoking Cessation; Systole; Tobacco Use Cessation Devices; Varenicline | 2016 |